Last edition
News about "calcified below-the-knee (BTK) lesions"
Johnson & Johnson MedTech has released the one-year results of its DISRUPT BTK II study, reaffirming the safety and durability of the Shockwave Peripheral Intravascular Lithotripsy (IVL) System for the treatment of calcified below-the-knee (BTK) lesions in patients with peripheral artery disease (PA
Calcified Below-the-knee (BTK) Lesions | 04/11/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members